Tuberculosis vaccines: Rising opportunities.

by Johan Vekemans, Katherine L O'Brien, Jeremy Farrar
Published 2019-04-01

Research and development of new tuberculosis vaccines: a review [version 1; referees: 2 approved, 1 approved with reservations]

by Lewis K. Schrager, Rebecca C. Harris, Johan Vekemans
Published 2018-11-01

Research and development of new tuberculosis vaccines: a review [version 2; referees: 3 approved, 1 approved with reservations]

by Lewis K. Schrager, Rebecca C. Harris, Johan Vekemans
Published 2019-02-01

Vaccine impact on antimicrobial resistance to inform Gavi, the Vaccine Alliance’s 2018 Vaccine Investment Strategy: report from an expert survey [version 1; peer review: 2 approved...

by Maya Malarski, Mateusz Hasso-Agopsowicz, Adam Soble, Wilson Mok, Sophie Mathewson, Johan Vekemans
Published 2019-09-01

Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries [version 1; referees: 2 appro...

by Miwako Kobayashi, Johan Vekemans, Carol J. Baker, Adam J. Ratner, Kirsty Le Doare, Stephanie J. Schrag
Published 2016-09-01

A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E.

by Francis M Ndungu, Jedidah Mwacharo, Domtila Kimani, Oscar Kai, Philippe Moris, Erik Jongert, Johan Vekemans, Ally Olotu, Philip Bejon
Published 2012-01-01

Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children.

by Ally Olotu, Frederic Clement, Erik Jongert, Johan Vekemans, Patricia Njuguna, Francis M Ndungu, Kevin Marsh, Geert Leroux-Roels, Philip Bejon
Published 2014-01-01

Potential effect of age of BCG vaccination on global paediatric tuberculosis mortality: a modelling study

by Partho Roy, MB ChB, Johan Vekemans, MD, Andrew Clark, PhD, Colin Sanderson, ProfPhD, Rebecca C Harris, PhD, Richard G White, ProfPhD
Published 2019-12-01

Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial

by Robert A. van den Berg, Margherita Coccia, W. Ripley Ballou, Kent E. Kester, Christian F. Ockenhouse, Johan Vekemans, Erik Jongert, Arnaud M. Didierlaurent, Robbert G. van der Most
Published 2017-05-01

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.

by Ally Olotu, Philippe Moris, Jedidah Mwacharo, Johan Vekemans, Domtila Kimani, Michel Janssens, Oscar Kai, Erik Jongert, Marc Lievens, Amanda Leach, Tonya Villafana, Barbara Savarese, Kevin Marsh, Joe Cohen, Philip Bejon
Published 2011-01-01

Serological evidence of discrete spatial clusters of Plasmodium falciparum parasites.

by Philip Bejon, Louise Turner, Thomas Lavstsen, Gerald Cham, Ally Olotu, Chris J Drakeley, Marc Lievens, Johan Vekemans, Barbara Savarese, John Lusingu, Lorenz von Seidlein, Peter C Bull, Kevin Marsh, Thor G Theander
Published 2011-01-01

Safety, immunogenicity and duration of protection of the RTS,S/AS02(D) malaria vaccine: one year follow-up of a randomized controlled phase I/IIb trial.

by Pedro Aide, John J Aponte, Montse Renom, Tacilta Nhampossa, Jahit Sacarlal, Inacio Mandomando, Quique Bassat, Maria Nélia Manaca, Amanda Leach, Marc Lievens, Johan Vekemans, Marie-Claude Dubois, Christian Loucq, W Ripley Ballou, Joe Cohen, Pedro L Alonso
Published 2010-11-01

A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in Gabon.

by Bertrand Lell, Selidji Agnandji, Isabelle von Glasenapp, Sonja Haertle, Sunny Oyakhiromen, Saadou Issifou, Johan Vekemans, Amanda Leach, Marc Lievens, Marie-Claude Dubois, Marie-Ange Demoitie, Terrell Carter, Tonya Villafana, W Ripley Ballou, Joe Cohen, Peter G Kremsner
Published 2009-10-01

Induction of Plasmodium falciparum-specific CD4+ T cells and memory B cells in Gabonese children vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D).

by Selidji T Agnandji, Rolf Fendel, Michaël Mestré, Michel Janssens, Johan Vekemans, Jana Held, Ferdinand Gnansounou, Sonja Haertle, Isabel von Glasenapp, Sunny Oyakhirome, Ludovic Mewono, Philippe Moris, Marc Lievens, Marie-Ange Demoitie, Patrice M Dubois, Tonya Villafana, Erik Jongert, Aurelie Olivier, Joe Cohen, Meral Esen, Peter G Kremsner, Bertrand Lell, Benjamin Mordmüller
Published 2011-04-01

Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine.

by Matthew B Laurens, Bourema Kouriba, Elke Bergmann-Leitner, Evelina Angov, Drissa Coulibaly, Issa Diarra, Modibo Daou, Amadou Niangaly, William C Blackwelder, Yukun Wu, Joe Cohen, W Ripley Ballou, Johan Vekemans, David E Lanar, Sheetij Dutta, Carter Diggs, Lorraine Soisson, D Gray Heppner, Ogobara K Doumbo, Christopher V Plowe, Mahamadou A Thera
Published 2017-01-01

Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy.

by Jason W Bennett, Anjali Yadava, Donna Tosh, Jetsumon Sattabongkot, Jack Komisar, Lisa A Ware, William F McCarthy, Jessica J Cowden, Jason Regules, Michele D Spring, Kristopher Paolino, Joshua D Hartzell, James F Cummings, Thomas L Richie, Joanne Lumsden, Edwin Kamau, Jittawadee Murphy, Cynthia Lee, Falgunee Parekh, Ashley Birkett, Joe Cohen, W Ripley Ballou, Mark E Polhemus, Yannick F Vanloubbeeck, Johan Vekemans, Christian F Ockenhouse
Published 2016-02-01

Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial

by Hans de Graaf, Ruth O. Payne, Iona Taylor, Kazutoyo Miura, Carol A. Long, Sean C. Elias, Marija Zaric, Angela M. Minassian, Sarah E. Silk, Lee Li, Ian D. Poulton, Megan Baker, Simon J. Draper, Diane Gbesemete, Nathan J. Brendish, Filipa Martins, Arianna Marini, David Mekhaiel, Nick J. Edwards, Rachel Roberts, Johan Vekemans, Sarah Moyle, Saul N. Faust, Eleanor Berrie, Alison M. Lawrie, Fergal Hill, Adrian V. S. Hill, Sumi Biswas
Published 2021-07-01

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01E in 5 to 17 Month Old Kenyan and Tanzanian Children

by John Lusingu, Ally Olotu, Amanda Leach, Marc Lievens, Johan Vekemans, Aurélie Olivier, Sarah Benns, Raimos Olomi, Salum Msham, Trudie Lang, Jayne Gould, Karin Hallez, Yolanda Guerra, Patricia Njuguna, Ken O. Awuondo, Anangisye Malabeja, Omar Abdul, Samwel Gesase, Denise Dekker, Lincoln Malle, Sadiki Ismael, Neema Mturi, Chris J. Drakeley, Barbara Savarese, Tonya Villafana, W. Ripley Ballou, Joe Cohen, Eleanor M. Riley, Martha M. Lemnge, Kevin Marsh, Philip Bejon, Lorenz von Seidlein
Published 2010-01-01

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01E in 5 to 17 Month Old Kenyan and Tanzanian Children

by John Lusingu, Ally Olotu, Amanda Leach, Marc Lievens, Johan Vekemans, Aurélie Olivier, Sarah Benns, Raimos Olomi, Salum Msham, Trudie Lang, Jayne Gould, Karin Hallez, Yolanda Guerra, Patricia Njuguna, Ken O. Awuondo, Anangisye Malabeja, Omar Abdul, Samwel Gesase, Denise Dekker, Lincoln Malle, Sadiki Ismael, Neema Mturi, Chris J. Drakeley, Barbara Savarese, Tonya Villafana, W. Ripley Ballou, Joe Cohen, Eleanor M. Riley, Martha M. Lemnge, Kevin Marsh, Philip Bejon, Lorenz von Seidlein
Published 2010-01-01

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01 in 5 to 17 Month Old Kenyan and Tanzanian Children.

by John Lusingu, Ally Olotu, Amanda Leach, Marc Lievens, Johan Vekemans, Aurélie Olivier, Sarah Benns, Raimos Olomi, Salum Msham, Trudie Lang, Jayne Gould, Karin Hallez, Yolanda Guerra, Patricia Njuguna, Ken O. Awuondo, Anangisye Malabeja, Omar Abdul, Samwel Gesase, Denise Dekker, Lincoln Malle, Sadiki Ismael, Neema Mturi, Chris J. Drakeley, Barbara Savarese, Tonya Villafana, W. Ripley Ballou, Joe Cohen, Eleanor M. Riley, Martha M. Lemnge, Kevin Marsh, Philip Bejon, Lorenz von Seidlein
Published 2010-01-01